CerebrAlcare Pills on CereBral Small VesseL DiseasE（CABLE）
Status:
Active, not recruiting
Trial end date:
2024-03-31
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blinded, placebo-controlled, multicenter trial. Cerebral small
vessel disease (CSVD) patients will be diagnosed by Magnetic Resonance Imaging (MRI) and
randomized into treatment or control groups. The purpose of this trial is to assess the
efficacy of cerebralcare pills on cerebral small vessel disease.